Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viking Therapeutics Inc VKTX

Healthcare Biotechnology
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b... see more

NDAQ:VKTX - Post Discussion

Viking Therapeutics Inc > VKTX Price Target Alert: $105.00. Issued by Morgan Stanley
View:
Post by whytestocks on Jun 27, 2024 1:30pm

VKTX Price Target Alert: $105.00. Issued by Morgan Stanley

NEWS: $VKTX VKTX Price Target Alert: $105.00. Issued by Morgan Stanley2024-06-27 06:00:08 ET Michael Ulz from Morgan Stanley issued a price target of $105.00 for VKTX on 2024-06-27 04:57:00. The adjusted price target was set to $105.00. At the time of the announcement, VKTX was trading at $47.39. The overall price target consensus is at $9...VKTX - VKTX Price Target Alert: $105.00. Issued by Morgan Stanley
Be the first to comment on this post
Viking Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities